Annual Drug Patent Expirations for TECFIDERA
Tecfidera is a drug marketed by Biogen Inc and is included in one NDA. It is available from two suppliers. There are eight patents protecting this drug and one Paragraph IV challenge.
Drug patent litigation for TECFIDERA.
This drug has fifty-one patent family members in twenty-two countries.
The generic ingredient in TECFIDERA is dimethyl fumarate. Two suppliers are listed for this compound. Additional details are available on the dimethyl fumarate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
